Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyMeta-analysisPublished in a peer-reviewed journal

Effects of Blood Flow Restriction Therapy on Lower-Limb Strength in Multiple Sclerosis: A Meta-Analysis

A meta-analysis of five studies found that blood flow restriction (BFR) therapy may improve lower-limb strength in people with MS, particularly for hamstrings over quadriceps, and may reduce fatigue compared to exercise alone. However, the evidence on quadriceps strength was less certain after sensitivity analysis.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
Moderate
Outcome
Not reported

Why it matters

This analysis suggests that BFR therapy could be a beneficial rehabilitation strategy for lower-limb strength in MS, addressing challenges associated with traditional exercises. It adds to the understanding of alternative training methods for this population.

What this does not prove

The study did not establish definitive benefits for sit-to-stand or gait outcomes, nor did it compare BFR therapy efficacy against high-load training. Optimal BFR parameters remain unclear, impacting application in clinical settings.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Meta-analysis
Participants / samples
5 · Five studies met the inclusion criteria.
Randomised
Not applicable
Controlled
Not applicable
Primary endpoint met
Not applicable
Relevant MS type
Not reported
Publication date
2026-10-12
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
Not reported
Size of effect
SMD=-0.55 for quadriceps strength; SMD=-0.38 for hamstring strength; SMD=-0.35 for fatigue
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (17)
subjectsClinical and quasi-experimental studies involving people with MS that evaluated lower-limb BFR interventions were included, with lower-limb muscle strength as the primary outcome.
sample sizeFive studies met the inclusion criteria.
sample size basisFive studies met the inclusion criteria.
peer reviewedJournal Article; Review
publication date2026-10-12
interventionBlood flow restriction (BFR) therapy has emerged as a promising low-load rehabilitation strategy, although evidence in people with MS (pwMS) remains limited and heterogeneous.
comparatorCONCLUSIONS: BFR therapy may improve lower-limb strength (more consistently for hamstrings than quadriceps) and may reduce fatigue in people with MS compared with exercise alone, but the certainty of the evidence is low.
primary endpointClinical and quasi-experimental studies involving people with MS that evaluated lower-limb BFR interventions were included, with lower-limb muscle strength as the primary outcome.
findingsCONCLUSIONS: BFR therapy may improve lower-limb strength (more consistently for hamstrings than quadriceps) and may reduce fatigue in people with MS compared with exercise alone, but the certainty of the evidence is low.
limitationsThe evidence does not allow conclusions on equivalence to high-load training or on optimal occlusion pressure or intervention duration.
effect sizeCompared with exercise alone, exercise combined with BFR significantly improved quadriceps (SMD=-0.55) and hamstring strength (SMD=-0.38), and possibly reduced fatigue (SMD=-0.35), with low heterogeneity across analyses.
peer reviewedPublication types: Journal Article; Review
study designTitle: Effects of blood flow restriction therapy on lower-limb strength in multiple sclerosis: A systematic review and meta-analysis.
study phaseTitle: Effects of blood flow restriction therapy on lower-limb strength in multiple sclerosis: A systematic review and meta-analysis.
randomizedTitle: Effects of blood flow restriction therapy on lower-limb strength in multiple sclerosis: A systematic review and meta-analysis.
controlledTitle: Effects of blood flow restriction therapy on lower-limb strength in multiple sclerosis: A systematic review and meta-analysis.
primary endpoint metTitle: Effects of blood flow restriction therapy on lower-limb strength in multiple sclerosis: A systematic review and meta-analysis.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.